Sfoglia per Autore
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury.
2007 Caraceni P; Giannone F; Catani L; Talarico S; Pertosa AM; Domenicali M; Fogli M; Principe A; Trevisani F; Baccarani M; Bernardi M; Lemoli RM.
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia.
2009 Caraceni P; Pertosa AM; Giannone F; Domenicali M; Grattagliano I; Perrelli MG; Principe A; Mastroleo C; Cutrin J; Trevisani F; Croci T; Bernardi M.
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis
2009 Caraceni P, Domenicali M, Viola A, Piscitelli F, Petrosino S, Giannone F, Berzigotti A, Cescon M, Grazi G.L, Golfieri R, Zoli M, Di Marzo V, Bernardi M.
The role of the endocannabinoid system in liver diseases.
2009 Caraceni P; Domenicali M; Giannone F; Bernardi M.
A novel model of CCl4-induced cirrosi with ascites in the mouse.
2009 Domenicali M; Caraceni P; Giannone F; Baldassarre M; Lucchetti G; Quarta C; Patti C; Catani L; Nanni C; Lemoli RM; Bernardi M.
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
2009 Domenicali M; Caraceni P; Giannone F; Pertosa; Principe A; Zambruni A; Trevisani F; Croci T; Bernardi M.
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis
2010 Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma M; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V.
Effetto dell’antagonismo farmacologico dei recettori per gli endocannabinoidi sull’equilibrio idrosodico nella cirrosi epatica. Prospettive terapeutiche. [Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis]
2011 Montanari, Giancarlo; Santi, Luca; Giannone, Ferdinando; Morieri, Mario Luca; Domenicali, Marco; Caraceni, Paolo; Bernardi, Mauro
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1-receptor in a rat model of CCl4-induced advanced cirrhosis.
2012 Giannone F; Baldassarre M; Domenicali M; Zaccherini G; Trevisani F; Bernardi M; Caraceni P.
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury
2012 Giannone FA; Trerè D; Domenicali M; Grattagliano I; Baracca A; Sgarbi G; Maggioli C; Longobardi P; Solaini G; Derenzini M; Bernardi M; Caraceni P.
Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A.
2012 Vasina V; Giannone F; Domenicali M; Latorre R; Berzigotti A; Caraceni P; Zoli M; De Ponti F; Bernardi M.
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field.
2013 Naldi M; Giannone FA; Baldassarre M; Domenicali M; Caraceni P; Bernardi M; Bertucci C.
Androgen receptor expression in the human vagina under different physiological and treatment conditions
2013 Baldassarre M.; Perrone A.M.; Giannone F.A.; Armillotta F.; Battaglia C.; Costantino A.; Venturoli S.; Meriggiola M.C.
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.
2014 Brighenti E;Calabrese C;Liguori G;Giannone FA;Trerè D;Montanaro L;Derenzini M
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis.
2014 Domenicali M; Baldassarre M; Giannone FA; Naldi M; Mastroroberto M; Biselli M; Laggetta M; Patrono D; Bertucci C; Bernardi M; Caraceni P.
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis.
2015 Giannone FA; Domenicali M; Baldassarre M; Bartoletti M; Naldi M; Laggetta M; Bertucci C; Clecchia A; Viale P; Bernardi M; Caraceni P.
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases.
2015 Naldi M; Baldassarre M; Nati M; Laggetta M; Giannone FA; Domenicali M; Bernardi M; Caraceni P; Bertucci C.
Response to The reduced CO2+ -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus"
2015 Giannone, Ferdinando A.; Domenicali, Marco; Baldassarre, Maurizio; Caraceni, Paolo
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis.
2016 Naldi, M; Baldassarre, M; Domenicali, M; Giannone, Fa; Bossi, M; Montomoli, J; Sandahl, Td; Glavind, E; Vilstrup, H; Caraceni, P; Bertucci, C.
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate
2016 Brighenti, Elisa; Giannone, Ferdinando Antonino; Fornari, Francesca; Onofrillo, Carmine; Govoni, Marzia; Montanaro, Lorenzo; Treré, Davide; Derenzini, Massimo
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. | Caraceni P; Giannone F; Catani L; Talarico S; Pertosa AM; Domenicali M; Fogli M; Principe A; Trev...isani F; Baccarani M; Bernardi M; Lemoli RM. | 2007-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. | Caraceni P; Pertosa AM; Giannone F; Domenicali M; Grattagliano I; Perrelli MG; Principe A; Mastro...leo C; Cutrin J; Trevisani F; Croci T; Bernardi M. | 2009-01-01 | GUT | - | 1.01 Articolo in rivista | - |
| Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis | Caraceni P, Domenicali M, Viola A, Piscitelli F, Petrosino S, Giannone F, Berzigotti A, Cescon M,... Grazi G.L, Golfieri R, Zoli M, Di Marzo V, Bernardi M. | 2009-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| The role of the endocannabinoid system in liver diseases. | Caraceni P; Domenicali M; Giannone F; Bernardi M. | 2009-01-01 | BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL ENDOCRINOLOGY & METABOLISM | - | 1.01 Articolo in rivista | - |
| A novel model of CCl4-induced cirrosi with ascites in the mouse. | Domenicali M; Caraceni P; Giannone F; Baldassarre M; Lucchetti G; Quarta C; Patti C; Catani L; Na...nni C; Lemoli RM; Bernardi M. | 2009-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. | Domenicali M; Caraceni P; Giannone F; Pertosa; Principe A; Zambruni A; Trevisani F; Croci T; Bern...ardi M. | 2009-01-01 | GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis | Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S;... Giampalma M; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V. | 2010-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Effetto dell’antagonismo farmacologico dei recettori per gli endocannabinoidi sull’equilibrio idrosodico nella cirrosi epatica. Prospettive terapeutiche. [Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis] | Montanari, Giancarlo; Santi, Luca; Giannone, Ferdinando; Morieri, Mario Luca; Domenicali, Marco; ...Caraceni, Paolo; Bernardi, Mauro | 2011-01-01 | RECENTI PROGRESSI IN MEDICINA | - | 1.01 Articolo in rivista | - |
| Reversal of liver fibrosis by the antagonism of endocannabinoid CB1-receptor in a rat model of CCl4-induced advanced cirrhosis. | Giannone F; Baldassarre M; Domenicali M; Zaccherini G; Trevisani F; Bernardi M; Caraceni P. | 2012-01-01 | LABORATORY INVESTIGATION | - | 1.01 Articolo in rivista | - |
| An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury | Giannone FA; Trerè D; Domenicali M; Grattagliano I; Baracca A; Sgarbi G; Maggioli C; Longobardi P...; Solaini G; Derenzini M; Bernardi M; Caraceni P. | 2012-01-01 | THE SCIENTIFIC WORLD JOURNAL | - | 1.01 Articolo in rivista | Hyperbarism.pdf |
| Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A. | Vasina V; Giannone F; Domenicali M; Latorre R; Berzigotti A; Caraceni P; Zoli M; De Ponti F; Bern...ardi M. | 2012-01-01 | BRITISH JOURNAL OF PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. | Naldi M; Giannone FA; Baldassarre M; Domenicali M; Caraceni P; Bernardi M; Bertucci C. | 2013-01-01 | EUROPEAN JOURNAL OF MASS SPECTROMETRY | - | 1.01 Articolo in rivista | - |
| Androgen receptor expression in the human vagina under different physiological and treatment conditions | Baldassarre M.; Perrone A.M.; Giannone F.A.; Armillotta F.; Battaglia C.; Costantino A.; Venturol...i S.; Meriggiola M.C. | 2013-01-01 | INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | - | 1.01 Articolo in rivista | - |
| Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. | Brighenti E;Calabrese C;Liguori G;Giannone FA;Trerè D;Montanaro L;Derenzini M | 2014-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. | Domenicali M; Baldassarre M; Giannone FA; Naldi M; Mastroroberto M; Biselli M; Laggetta M; Patron...o D; Bertucci C; Bernardi M; Caraceni P. | 2014-01-01 | HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. | Giannone FA; Domenicali M; Baldassarre M; Bartoletti M; Naldi M; Laggetta M; Bertucci C; Clecchia... A; Viale P; Bernardi M; Caraceni P. | 2015-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. | Naldi M; Baldassarre M; Nati M; Laggetta M; Giannone FA; Domenicali M; Bernardi M; Caraceni P; Be...rtucci C. | 2015-01-01 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | - | 1.01 Articolo in rivista | - |
| Response to The reduced CO2+ -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus" | Giannone, Ferdinando A.; Domenicali, Marco; Baldassarre, Maurizio; Caraceni, Paolo | 2015-01-01 | LIVER INTERNATIONAL | - | 1.04 Replica / breve intervento (e simili) | - |
| Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. | Naldi, M; Baldassarre, M; Domenicali, M; Giannone, Fa; Bossi, M; Montomoli, J; Sandahl, Td; Glavi...nd, E; Vilstrup, H; Caraceni, P; Bertucci, C. | 2016-01-01 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | - | 1.01 Articolo in rivista | - |
| Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate | Brighenti, Elisa; Giannone, Ferdinando Antonino; Fornari, Francesca; Onofrillo, Carmine; Govoni, ...Marzia; Montanaro, Lorenzo; Treré, Davide; Derenzini, Massimo | 2016-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | Oncotarget2016Brighenti.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile